Ozempic, a medication used to treat type 2 diabetes and promote weight loss, has gained significant popularity in the pharmaceutical market. This is due to its effectiveness in managing blood sugar levels and its ability to aid in weight loss. As more people prioritize their health and wellness, the use of Ozempic and other GLP-1 drugs reflects this trend.
The widespread use of GLP-1 drugs has implications for various sectors within the US retail market, including grocery and apparel. Companies such as Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo, and Walmart are mentioned in this report, highlighting the potential impact on these businesses.
This exclusive report is only available to subscribers and provides valuable insights into how widespread GLP-1 drug use affects the retail industry. Subscribers can log in to access the document and gain a deeper understanding of this topic. If you are not a subscriber, you can learn more about subscriptions and access to relevant research.